Abstract |
To investigate the role of the costimulatory molecule CD226 in asthma pathogenesis, we produced a CD4+ T-cell-specific CD226 knockout mice model (Cd226ΔCD4) and induced airway allergic inflammation by administering ovalbumin (OVA). Our results revealed alleviated lung inflammation, decreased levels of OVA-specific IgE, and increased levels of IL-10 in the serum of Cd226ΔCD4 mice (P < 0.05). Moreover, IL-10 levels in CD4+ T cells were significantly elevated in the mediastinal lymph node, spleen, and Peyer's patches in the Cd226ΔCD4 mice compared with those in controls (P < 0.05 to P < 0.01). Notably, there was a significantly higher IL-10 mRNA levels in the large intestine of the mice (P < 0.05). The protective effect of CD226 deficiency is also associated with the accumulation of gut TCRγδ+ intraepithelial lymphocytes and reversion of the gut microbiome dysbiosis. The Bacteroidetes-to-Firmicutes ratio and the abundance of Akkermansia increased in the absence of CD226 after OVA treatment. Our data reveal the synchronous changes in the lung and intestine in OVA-treated CD226-knockout mice, supporting the gut-lung axis concept and providing evidence for novel therapeutic approaches for asthma.
|
Authors | Yang Xie, Yuan Zhang, Tingting Wang, Yitian Liu, Jingchang Ma, Shuwen Wu, Chujun Duan, Wei Qiao, Kun Cheng, Lianjun Lu, Ran Zhuang, Ka Bian |
Journal | International immunopharmacology
(Int Immunopharmacol)
Vol. 118
Pg. 110051
(May 2023)
ISSN: 1878-1705 [Electronic] Netherlands |
PMID | 36989896
(Publication Type: Journal Article)
|
Copyright | Copyright © 2023 Elsevier B.V. All rights reserved. |
Chemical References |
- Interleukin-10
- Ovalbumin
- Cytokines
|
Topics |
- Mice
- Animals
- Gastrointestinal Microbiome
- Interleukin-10
(genetics, therapeutic use)
- Asthma
(drug therapy)
- Mice, Knockout
- CD4-Positive T-Lymphocytes
- Ovalbumin
(therapeutic use)
- Mice, Inbred BALB C
- Disease Models, Animal
- Cytokines
(therapeutic use)
- Bronchoalveolar Lavage Fluid
|